PITTSBURGH — Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.
Mylan, through its Mylan Pharmaceuticals subsidiary, announced the launch of norethindrone tablets in the 0.35-mg strength. The drug is a generic version of Actavis' Nor-Q.D. tablets, which are taken on a 28-day cycle to prevent pregnancy. Mylan is partnering with Famy Care, which filed for and received Food and Drug Administration approval for the drug.
Norethindrone tablets in the 0.35-mg strength had sales of $39 million during the 12-month period that ended in March, according to IMS Health.